Baseline characteristics

A Study of Ixazomib Plus Lenalidomide and Dexamethasone in Adult Japanese Participants With Relapsed and/or Refractory Multiple Myeloma · Source last updated 2021-01-12

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      34

   units

   Participants

groups

1. description

   Ixazomib 4 mg, capsules, orally on Days 1, 8, and 15 plus lenalidomide 25 mg, capsule, orally, once daily on Days 1 through 21 and dexamethasone 40 mg, tablet, orally on Days 1, 8, 15, and 22 of a 28-day cycle up to 32 cycles.

   id

   BG000

   title

   Ixazomib 4 mg + Lenalidomide 25 mg + Dexamethasone 40 mg

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            spread

            8.57

            value

            65.2

   dispersion Type

   STANDARD_DEVIATION

   param Type

   MEAN

   title

   Age, Continuous

   unit Of Measure

   years

2. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            15

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            19

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Sex: Female, Male

   unit Of Measure

   Participants

3. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            34

         title

         Not Hispanic or Latino

      title

      Ethnicity

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Race/Ethnicity, Customized

   unit Of Measure

   Participants

4. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            34

         title

         Asian (Japanese)

      title

      Race

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Race/Ethnicity, Customized

   unit Of Measure

   Participants

5. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            34

      title

      Japan

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Region of Enrollment

   unit Of Measure

   Participants

6. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            spread

            9.738

            value

            159.88

   dispersion Type

   STANDARD_DEVIATION

   param Type

   MEAN

   title

   Height

   unit Of Measure

   centimeter (cm)

7. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            spread

            12.444

            value

            60.36

   dispersion Type

   STANDARD_DEVIATION

   param Type

   MEAN

   title

   Weight

   unit Of Measure

   kilogram (kg)

8. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            spread

            0.2076

            value

            1.632

   dispersion Type

   STANDARD_DEVIATION

   param Type

   MEAN

   title

   Body Surface Area

   unit Of Measure

   square meter (m^2)

population Description

Full Analysis Set (FAS) is defined as all participants who received at least one dose of the study drug during the treatment period.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice